期刊文献+

NF-κBp65在皮肤血管瘤不同时期的表达 被引量:2

EXPRESSION OF NF-κB p65 AT DIFFERENT STAGES OF HUMAN DERMAL HEMANGIOMAS
下载PDF
导出
摘要 目的 探讨NF κBp6 5在血管瘤发生、发展及退化过程中的表达状况及其意义。方法 采用免疫组织化学方法 (S P法 )检测人皮肤血管瘤增生期、退化期及正常皮肤组织及内皮中NF κBp6 5的表达水平。利用计算机图像分析技术测量不同时期血管瘤组织和正常皮肤组织NF κBp6 5表达的平均光密度和平均阳性面积。结果 增生期血管瘤内皮细胞NF κBp6 5表达水平高于退化期 ,差异有显著性 (P <0 0 1) ,退化期血管瘤内皮细胞NF κBp6 5表达水平与正常皮肤组织相比 ,差异无显著性 (P >0 0 5 )。结论 NF κBp6 5可能通过正向调控血管生成因子的表达而促进血管瘤的形成。 ? Objective To investigate the expression and significance of NF-κB p65in the occurrence, development and regression of human hemangiomas. Method We examined the expression of NF-κB p65 in proliferating and involuting human hemangiomas and normal skin tissues using immunohistochemical technique. An image analysis system was used to measure the average optical density and the rate of positive area of NF-κB p65 in different stages of hemangiomas and in normal skin tissues. Result The expression of NF-κB p65in the endothelium was significantly higher in proliferating than in degenerating hemangiomas (P<0.01), but there was no significant difference between degenerating hemangiomas and normal skin tissues. (P>0.05). Conclusion NF-κB p65 may provotehemangioma formation by modulatingthe expression of angiogenesis factors. 〔
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2004年第2期133-137,共5页 Chinese Journal of Histochemistry and Cytochemistry
基金 国家自然科学基金资助 (30 2 71345 ) 湖北省科技攻关课题资助 (2 0 0 2AA30 5B0 6 ) 湖北省自然科学基金资助 (2 0 0 3ABA16 4 )
关键词 血管瘤 核转录因子 血管生成因子 HemangiomaNF-κB p65Angiogenesisfactors
  • 相关文献

参考文献4

二级参考文献21

  • 1盛迎伦,郑庆璇,赵晖,赵福运.血管瘤和脉管畸形病变组织中肥大细胞特点的观察[J].中华病理学杂志,1994,23(5):311-311. 被引量:3
  • 2Iwata J, Sonobe H, Furihata M, et al. High frequency of apoptosis in infantile capillary haemangioma. J Pathol, 1996 , 179 (4). 403-408.
  • 3Razon MJ, Kraling BM, Mulliken JB, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation, 1998, 5 (2-3): 189-195.
  • 4Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg, 1982, 69 (3): 412-422.
  • 5Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 ;69: 412
  • 6Kraling BM, Razon MJ, Boon LM, et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 1996; 148: 1181
  • 7Forlkman J: Angiogenesis in cancer, vascular,rheumatoid and other diseases. Nature Med 1995; 9: 271
  • 8Friedlander M. Definition of two angiogenic pathways by distinct αV integrins. Science 1995; 270: 1500
  • 9Kim S, Bell K, Mousa SA, et al. Regulation of angiogenesis in vivo by ligand of integrin α5β1 with the central cell-binding domain of fibronectin. Am J Pathol 2000; 156: 1345
  • 10Allsa E. Angiogenesis is mediated by soluble forms of E-selectin and VCAM-1. Nature 1995;376:517

共引文献22

同被引文献22

  • 1Razon MJ, Kraling BM, Mulliken JB, et al. Increased apoptosis coincides with onset of involution in infantile hemangioma. Mircocirculation, 1998,5 : 189-195.
  • 2Muzio M, Chinnaiyan AM, Kischkei FC, et al. FLICE, a novel FADD homologous ICE/CED-3-1ike protease, is recruited to the CD95 (Fas/Apol) death inducing signaling complex (DISC). Cell, 1996,85 : 817-827.
  • 3Maedler K, Fontana A, Ris F, et al. FLIP switches Fasmediated glucose signaling in human pancreatic β cells from apoptosis to cell replication. Proc Natl Acad Sci USA, 2002, 99:8236-8241.
  • 4Kim Y, Suh N, Sporn M,et al. An inducible pathway for degradation of FLIP protein sensitizestumor eellsto TRAIL-induced apoptosis. J Biol Chem,2002,277: 22320- 22329.
  • 5Rescigno M, Piguet V, Valzasina B, et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-beta, and the production of interferon gamma in the absence of IL-12 during DC-Tcell cognate interaction: a new role for fas ligand in inflammatory responses. J Exp Med,2000, 192:1661-1668.
  • 6Kataoka T, Budd RC. The caspase-8 inhibitor FLIP promotes actievation of NF-kappB and Erk signaling pathways. Curt Biol, 2000,10 : 640-648.
  • 7Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest, 2002,109:437-441.
  • 8Okano H, Shiraki K, Inoue H,et al. Cellular FLICE/easpase-8- inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab Invest,2003,83:1033-1043.
  • 9Micheau O,Lens S,Gaide O,et al. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol,2001,21: 5299-5305.
  • 10Kreuz S, Siegmund D, Scheurich P, et al. NF-kappaB inducers upregulate c-FLIP,a cyclohexide-sensitive inhibitor of death signaling. Mol Cell Biol,2001,21:3964- 3973.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部